Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-28 @ 4:26 AM
Study NCT ID:
NCT05163834
Status:
COMPLETED
Last Update Posted:
2022-03-17
First Post:
2021-11-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV
Sponsor:
argenx
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-08
Completion Date Type:
ACTUAL
First Submit Date:
2021-11-23
First Submit QC Date:
None
Study First Post Date:
2021-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-03-16
Last Update Post Date:
2022-03-17
Last Update Post Date Type:
ACTUAL